about
Kineret®/IL-1ra blocks the IL-1/IL-8 inflammatory cascade during recombinant Panton Valentine Leukocidin-triggered pneumonia but not during S. aureus infectionIn vivo efficacy of ceftaroline fosamil in a methicillin-resistant panton-valentine leukocidin-producing Staphylococcus aureus rabbit pneumonia model.A leukocyte score to improve clinical outcome predictions in bacteremic pneumococcal pneumonia in adults.Ceftaroline versus ceftriaxone in a highly penicillin-resistant pneumococcal pneumonia rabbit model using simulated human dosing.Mechanical Ventilation Alters the Development of Staphylococcus aureus Pneumonia in RabbitMutant selection window in levofloxacin and moxifloxacin treatments of experimental pneumococcal pneumonia in a rabbit model of human therapy.Effectiveness of and obstacles to antibiotic streamlining to amoxicillin monotherapy in bacteremic pneumococcal pneumonia.Preliminary results of a new antibiotic susceptibility test against biofilm installation in device-associated infections: the Antibiofilmogram®.Generic vancomycin products: Analysis of serum concentrations in patients with acute myeloid leukemia.In vivo pharmacodynamic efficacy of gatifloxacin against Streptococcus pneumoniae in an experimental model of pneumonia: impact of the low levels of fluoroquinolone resistance on the enrichment of resistant mutants.Effect of low-level resistance on subsequent enrichment of fluoroquinolone-resistant Streptococcus pneumoniae in rabbits.In vivo efficacy of humanised intermittent versus continuous ceftazidime in combination with tobramycin in an experimental model of pseudomonal pneumonia.The impact of mechanical ventilation on the moxifloxacin treatment of experimental pneumonia caused by Streptococcus pneumoniae.Mechanical ventilation and Streptococcus pneumoniae pneumonia alter mitochondrial homeostasisPreventing lung pathology and mortality in rabbit Staphylococcus aureus pneumonia models with cytotoxin-neutralizing monoclonal IgGs penetrating the epithelial lining fluid[Mutation window for the "pneumococcus-fluoroquinolone" couple. Contribution of experimental models]Efficacy of humanlike Augmentin SR (2000/125 mg) twice daily treatment on Haemophilus influenzae experimental pneumonia in rabbitsFactors associated with mucoid transition of Pseudomonas aeruginosa in cystic fibrosis patientsIn-vivo impact of the MexXY efflux system on aminoglycoside efficacy in an experimental model of Pseudomonas aeruginosa pneumonia treated with tobramycinEfficacy of Bacteriophages in a Staphylococcus aureus Nondiabetic or Diabetic Foot Infection Murine ModelActivity of Different Antistaphylococcal Therapies, Alone or Combined, in a Rat Model of Methicillin-Resistant Staphylococcus epidermidis Osteitis without Implant
P50
Q31164686-DBB84C81-4CF1-4BAF-8CDB-528B536C1FB2Q33622755-08907AE1-00EF-4986-8482-0C0221B451E5Q34801968-59901CA9-0929-40A7-9799-96F4C06BF891Q35065778-EAEF7DA8-C525-4984-88E0-7D1A93F5A6B8Q36071632-64807C0A-4A45-41E7-BAF0-2D2E9C253471Q37733449-7109C7F8-D67B-468B-A514-9AA0E020958DQ38685453-6761E313-D0AC-4E08-BAE7-0AA57BFFF1EDQ42102366-94CF31D0-08B3-4D74-88CE-468395A6D4EFQ42217303-D1D7D45A-6EC8-4B23-BBA2-500B1A1AF92DQ45022845-47B80816-9E62-4C15-8E46-DF551BCA4EE9Q45066135-A60F352E-568E-4C89-9E20-93410028D701Q46356871-ABF64BC0-A0E3-4C71-95A0-277116B6EE9DQ46488324-18ADD9B7-D521-4856-8B20-451CEA7C2929Q58799687-B557160D-9885-4AB5-9396-23AFF6594592Q64105208-87D1F400-586C-465E-9D26-BB8417648088Q79344021-B5B54DE1-53A9-411B-9DEA-58223B642C0FQ79966418-F5848B7D-4BCC-4CB0-971A-7F9CA0EBE78FQ82208274-7BF11095-58C3-42D6-90B3-2168C0082236Q83211399-960551A7-CDF2-43E3-87D9-17CF16513A00Q91233288-964FA251-CA6F-4308-87A4-64554E5FAD4FQ91329209-F3CFB76D-28D2-4EBC-B78F-68C6699E31A6
P50
description
investigador
@es
researcher
@en
name
Delphine Croisier
@en
Delphine Croisier
@nl
type
label
Delphine Croisier
@en
Delphine Croisier
@nl
altLabel
Croisier D
@en
prefLabel
Delphine Croisier
@en
Delphine Croisier
@nl
P31
P496
0000-0002-8744-5832